Iqvia Holdings Inc. (IQV): Capital Expenditures
$603.00M
Year ended 2025-12-31
$588.00M
Trailing 12 months to 2026-03-31
-3.6%
3-year compound annual growth
-0.4%
5-year compound annual growth
+22.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $603.00M | +0.2% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $602.00M | -7.2% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $649.00M | -3.7% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $674.00M | +5.3% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $640.00M | +3.9% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $616.00M | +5.8% | 2023-02-15, From 2020-01-01 |
| 2019-12-31 | $582.00M | +26.8% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $459.00M | +24.4% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $369.00M | +125.0% | 2020-02-18, From 2017-01-01 |
| 2016-12-31 | $164.00M | +110.3% | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | $78.00M | -6.0% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $83.00M | -6.1% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $88.35M | +23.8% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $71.34M | -5.7% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | $75.68M | n/a | 2014-02-13, From 2011-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $603.00M | +0.2% |
| Icon PLC (ICLR) | 2025-12-31 | $174.21M | +3.7% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $219.15M | -5.9% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $31.36M | -14.2% |
| NRC Health (NRC) | 2025-12-31 | $10.71M | -30.7% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $1.77M | +7.1% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $565.0K | -69.9% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $62.0K | n/a |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $60.6K | -23.4% |
Compare IQV, ICLR, CRL, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗